Hopamine as Personalized Medicine for Persons with Parkinson's Disease

J Parkinsons Dis. 2023;13(2):271-277. doi: 10.3233/JPD-230012.

Abstract

Prescribing dopamine replacement therapy remains the most common approach used by physicians who strive to support persons with Parkinson's disease. In this viewpoint, we argue that instead of merely prescribing dopamine, healthcare professionals should particularly encourage and enable persons with Parkinson's disease to draft their own personalized prescription of "hopamine". The term hopamine is a self-invented neologism representing the uniquely personal set of hopes, desires, experiences, and skills of each individual with a dopamine deficit. As such, the concept of hopamine-as a reflection of the unique personal characteristics of each person with Parkinson's disease-really supplements that of dopamine-as a reflection of each person's unique physical characteristics. Whereas a prescription of dopamine replacement medication necessitates the diagnosed individual to lay his or her fate in the hands of medical professionals, adding a personalized dose of hopamine to the therapeutic mix empowers persons to self-manage daily life with Parkinson's disease. In this viewpoint, we argue that hopamine is a prerequisite for personalized medicine and offer several practical recommendations for how medical professionals can introduce the concept of hopamine in daily clinical practice.

Keywords: Dopamine; Parkinson’s disease; hopamine; hope; personalized care management; personalized medicine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cognition
  • Dopamine
  • Dopamine Agents / therapeutic use
  • Female
  • Humans
  • Male
  • Parkinson Disease* / drug therapy
  • Precision Medicine

Substances

  • Dopamine
  • Dopamine Agents